ArticleUltrasonics sonochemistry2025
Ultrasonic replacement of natural aging: Potential strategies for improving the color, antioxidant activity, and volatile compound profile of astragalus mead.
Article in Ultrasonics sonochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Ultrasound - assisted sodium alginate coating pretreatment integrated with advanced drying technologies: A novel strategy to optimize drying behavior, energy consumption, physicochemical quality, and sensory attributes of Zanthoxylum bungeanum.Ultrasonics sonochemistry · 2026Article
- Characterisation of volatile compounds and antioxidant properties of Astragalus glycyphyllos leaves and roots extracts isolated by consecutive extraction with supercritical COAnalytical and bioanalytical chemistry · 2026Article
- Effect of ultrasound-assisted extraction combined with enzymatic pretreatment on bioactive compounds, antioxidant capacity and flavor characteristics of grape pulp extracts.Ultrasonics sonochemistry · 2025Article
- Preparation ofInternational journal of food science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing demand for natural and functional beverages has driven research aimed at improving the quality of herbal meads. This study investigates the use of non-thermal processing methods, ultrasonic, microwave, and high hydrostatic pressure processing, as alternatives to traditional natural aging for improving the physicochemical properties, antioxidant activity, color stability, and volatile compound profile of astragalus mead. Response surface methodology was employed to optimize fermentation conditions, which yielded the highest flavonoid content and sensory quality at an impregnation time of 12 h, an impregnation temperature of 10 °C, and a fermentation temperature of 20 °C. Among the processing methods evaluated (natural aging, ultrasound, microwave irradiation, and high hydrostatic pressure), ultrasound treatment resulted in the most significant improvements. Specifically, it increased total phenol content by 7.22 %, total flavonoid content by 9.41 %, and antioxidant capacity by 65.43 %. Volatile compound analysis also revealed a 191.30 % increase in ester content, significantly enhancing floral and fruity notes. Sensory analysis using quantitative descriptive analysis, partial least squares discriminant analysis, and weighted gene co-expression network analysis confirmed the efficacy of ultrasound, with ethyl caprylate identified as a key aroma contributor. These findings suggest that ultrasound is an effective non-thermal processing technique for improving the aging process and overall quality of astragalus mead. This study provides valuable insights for the industrial application of non-thermal processing technologies in astragalus mead production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.